U.S. Physical Therapy Inc.
USPH | undefined
-
At close: undefined
-
After-hours:
Market Data
Market Cap $1.25B
Enterprise Value $1.4B
Beta 1.13
Average Volume 225.77K
Shares Outstanding (Diluted) 15.12M
Shares Change YoY -0.52%
Institutional Ownership N/A
Exchange NYSE
ISIN US90337L1089
Price Performance
Price Change 1M 4.5%
Price Change 3M 29.8%
Price Change 6M 10.0%
Price Change YTD 4.5%
Price Change 1Y 3.2%
Price Change 3Y -13.5%
Price Change 5Y -28.9%
1M CAGR (ann.) 3.6%
1Y CAGR (ann.) 5.5%
5Y CAGR (ann.) -4.2%
All-Time CAGR 11.5%
Valuation
PE Ratio 485.00
Forward PE 23.90
PEG Ratio -5.24
Forward PEG 20.14
PS Ratio 1.78
Forward PS 1.40
PB Ratio 2.80
P/FCF Ratio 20.01
P/Adj. FCF Ratio 23.75
P/OCF Ratio 14.96
EV/Sales 1.99
EV/EBIT 25.05
EV/EBITDA 15.77
EV/FCF 22.35
Earnings Yield 0.2%
FCF Yield 5.0%
Adj. FCF Yield 4.2%
Financial Health
Net Debt $146.34M
Total Debt $171.22M
Cash & Short-Term Investments $24.89M
Total Assets $1.25B
Current Ratio 1.27
Quick Ratio 1.27
Debt / Equity Ratio 0.86
Debt / EBITDA 1.93
Debt / FCF 2.73
OCF / Debt 0.51
Interest Coverage 7.83
Altman Z-Score 2.54
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 19.2%
Operating Profit Margin 12.0%
EBITDA Margin 12.9%
Net Profit Margin -0.8%
FCF Margin 8.9%
Adj. FCF Margin 7.5%
SBC / Revenue 1.3%
SBC Impact (per share) -15.7%
Returns
Return on Assets -0.5%
Return on Equity -1.3%
Return on Invested Capital 5.3%
Return on Capital Employed 7.4%
Return on Tangible Assets -1.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.6%
Revenue CAGR 5Y 8.6%
Revenue CAGR 10Y 7.3%
EPS CAGR 3Y -58.9%
EPS CAGR 5Y -42.7%
EPS CAGR 10Y -21.0%
FCF CAGR 3Y 0.6%
FCF CAGR 5Y -5.0%
FCF CAGR 10Y 2.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.76
EPS Growth Est (next Q) 15.2%
Revenue Est (next Q) $214.48M
Revenue Growth Est (next Q) 30.8%
Fair Value Estimates
Graham Number $13.95
Graham Upside -83.1%
Lynch Fair Value $0.85
Lynch Upside -99.0%
Price Target $90
Price Target Upside 9.2%
Cash Flow
Operating Cash Flow $87.05M
Free Cash Flow $62.7M
Adj. Free Cash Flow $52.84M
FCF Per Share $4.25
OCF Per Share $5.51
OCF/S Ratio 10.7%
Income Statement
Revenue $704.3M
Gross Profit $153.43M
Operating Income $84.23M
EBITDA $88.87M
Net Income $2.26M
EPS (Diluted) $0.17
Revenue / Employee $110.5K
Profit / Employee $355.04
Employees 6,374
Dividends
Annual Dividend $1.83
Dividend Yield 2.22%
Payout Ratio 1076.5%
FCF Payout Ratio 44.0%
Adj. FCF Payout Ratio 52.1%
Dividend Growth (YoY) 2.2%
Pay Frequency Quarterly
Ex-Dividend Date Aug 20, 2026
Add to Watchlist
Select watchlists to add or remove USPH